Mobic and Antinuclear antibody positive - a phase IV clinical study of FDA data

Summary:

Antinuclear antibody positive is found among people who take Mobic, especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Mobic and have Antinuclear antibody positive. It is created by eHealthMe based on reports of 24,026 people who have side effects when taking Mobic from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

24,026 people reported to have side effects when taking Mobic.
Among them, 23 people (0.1%) have Antinuclear antibody positive.


What is Mobic?

Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 25,681 Mobic users for its effectiveness, alternative drugs and more.

What is Antinuclear antibody positive?

Antinuclear antibody positive is found to be associated with 1,026 drugs and 601 conditions by eHealthMe.

Number of Mobic and Antinuclear antibody positive reports submitted per year:

Could Mobic cause Antinuclear antibody positive?

Time on Mobic when people have Antinuclear antibody positive *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 50 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Antinuclear antibody positive when taking Mobic *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Antinuclear antibody positive when taking Mobic *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 10 %
  • 40-49: 0.0 %
  • 50-59: 60 %
  • 60+: 30 %

Common drugs people take besides Mobic *:

  1. Methotrexate: 7 people, 30.43%
  2. Synthroid: 6 people, 26.09%
  3. Ziac: 6 people, 26.09%
  4. Lovastatin: 6 people, 26.09%
  5. Aredia: 6 people, 26.09%
  6. Aromasin: 6 people, 26.09%
  7. Prednisone: 6 people, 26.09%
  8. Vicodin: 6 people, 26.09%
  9. Lodine: 6 people, 26.09%
  10. Prilosec: 6 people, 26.09%

Common side effects people have besides Antinuclear antibody positive *:

  1. Joint Pain: 12 people, 52.17%
  2. Musculoskeletal Discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves): 10 people, 43.48%
  3. Neuropathy Peripheral (surface nerve damage): 10 people, 43.48%
  4. Rashes (redness): 8 people, 34.78%
  5. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 8 people, 34.78%
  6. Colitis (inflammation of colon): 8 people, 34.78%
  7. Fatigue (feeling of tiredness): 8 people, 34.78%
  8. Infection: 8 people, 34.78%
  9. Itching: 8 people, 34.78%
  10. Weakness: 8 people, 34.78%

Common conditions people have *:

  1. Iron Overload: 4 people, 17.39%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 13.04%
  3. Joint Pain: 3 people, 13.04%
  4. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 3 people, 13.04%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 8.70%
  6. Tendonitis (a condition that causes pain and swelling of tendons): 1 person, 4.35%
  7. Herniated Nucleus Pulposus (Slipped Disk): 1 person, 4.35%
  8. Constipation: 1 person, 4.35%
  9. Birth Control: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Mobic and have Antinuclear antibody positive?

Check whether Antinuclear antibody positive is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Antinuclear antibody positive and when was it recovered:

Expand to all the drugs that have ingredients of meloxicam:

Alternative drugs to, pros and cons of Mobic:

Common Mobic side effects:

Browse all side effects of Mobic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Antinuclear antibody positive treatments and more:

COVID vaccines that are related to Antinuclear antibody positive:

Common drugs associated with Antinuclear antibody positive:

All the drugs that are associated with Antinuclear antibody positive:

Common conditions associated with Antinuclear antibody positive:

All the conditions that are associated with Antinuclear antibody positive:

How the study uses the data?

The study uses data from the FDA. It is based on meloxicam (the active ingredients of Mobic) and Mobic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: